Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Baker

Showing results (161-170 of 169) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 169 results.
Trials|January 28, 2015
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trialPatrick N A Harris, Anton Y Peleg, Jon Iredell, et al.
Journal of the American Geriatrics Society|May 27, 2016
Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and AgeMark H Eckman, Gregory Y H Lip, Ruth E Wise, et al.
American Heart Journal|June 7, 2016
Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillationMark H Eckman, Gregory Y H Lip, Ruth E Wise, et al.
Circulation. Cardiovascular Quality and Outcomes|September 11, 2014
Integrating real-time clinical information to provide estimates of net clinical benefit of antithrombotic therapy for patients with atrial fibrillationMark H Eckman, Ruth E Wise, Barbara Speer, et al.
Blood Advances|August 13, 2021
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignanciesJennifer L Crombie, Amy C Sherman, Chi-An Cheng, et al.
Scientific Reports|January 13, 2022
Female and male mice have differential longterm cardiorenal outcomes following a matched degree of ischemia-reperfusion acute kidney injuryDanielle E Soranno, Peter Baker, Lara Kirkbride-Romeo, et al.
Human Reproduction Open|May 3, 2024
Current global status of male reproductive healthChristopher J De Jonge, Christopher L R Barratt, R John Aitken, et al.
American Journal of Respiratory and Critical Care Medicine|September 22, 2007
Diffuse lung disease in young children: application of a novel classification schemeGail H Deutsch, Lisa R Young, Robin R Deterding, et al.
JAMA|September 13, 2018
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical TrialPatrick N A Harris, Paul A Tambyah, David C Lye, et al.
Pageof 17

Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Trials|January 28, 2015
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trialPatrick N A Harris, Anton Y Peleg, Jon Iredell, et al.
Journal of the American Geriatrics Society|May 27, 2016
Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and AgeMark H Eckman, Gregory Y H Lip, Ruth E Wise, et al.
American Heart Journal|June 7, 2016
Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillationMark H Eckman, Gregory Y H Lip, Ruth E Wise, et al.
Circulation. Cardiovascular Quality and Outcomes|September 11, 2014
Integrating real-time clinical information to provide estimates of net clinical benefit of antithrombotic therapy for patients with atrial fibrillationMark H Eckman, Ruth E Wise, Barbara Speer, et al.
Blood Advances|August 13, 2021
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignanciesJennifer L Crombie, Amy C Sherman, Chi-An Cheng, et al.
Scientific Reports|January 13, 2022
Female and male mice have differential longterm cardiorenal outcomes following a matched degree of ischemia-reperfusion acute kidney injuryDanielle E Soranno, Peter Baker, Lara Kirkbride-Romeo, et al.
Human Reproduction Open|May 3, 2024
Current global status of male reproductive healthChristopher J De Jonge, Christopher L R Barratt, R John Aitken, et al.
American Journal of Respiratory and Critical Care Medicine|September 22, 2007
Diffuse lung disease in young children: application of a novel classification schemeGail H Deutsch, Lisa R Young, Robin R Deterding, et al.
JAMA|September 13, 2018
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical TrialPatrick N A Harris, Paul A Tambyah, David C Lye, et al.
Pageof 17